Works matching IS 00070920 AND DT 2010 AND VI 102 AND IP 6

Results: 24

MutSbeta exceeds MutSalpha in dinucleotide loop repair.

Published in:

2010

By:

Kantelinen, J.;
Kansikas, M.;
Korhonen, M. K.;
Ollila, S.;
Heinimann, K.;
Kariola, R.;
Nyström, M.;
Nyström, M

Publication type:

journal article

The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial.

Published in:

2010

By:

Seebacher, V.;
Polterauer, S.;
Grimm, C.;
Husslein, H.;
Leipold, H.;
Hefler-Frischmuth, K.;
Tempfer, C.;
Reinthaller, A.;
Hefler, L.

Publication type:

journal article

High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.

Published in:

2010

By:

Dômont, J.;
Salas, S.;
Lacroix, L.;
Brouste, V.;
Saulnier, P.;
Terrier, P.;
Ranchère, D.;
Neuville, A.;
Leroux, A.;
Guillou, L.;
Sciot, R.;
Collin, F.;
Dufresne, A.;
Blay, J.-Y.;
Le Cesne, A.;
Coindre, J.-M.;
Bonvalot, S.;
Bénard, J.;
Dômont, J;
Ranchère, D

Publication type:

journal article

8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer.

Published in:

2010

By:

Sova, H.;
Jukkola-Vuorinen, A.;
Puistola, U.;
Kauppila, S.;
Karihtala, P.

Publication type:

journal article

Preferences for colorectal cancer screening strategies: a discrete choice experiment.

Published in:

2010

By:

Hol, L.;
de Bekker-Grob, E. W.;
van Dam, L.;
Donkers, B.;
Kuipers, E. J.;
Habbema, J. D. F.;
Steyerberg, E. W.;
van Leerdam, M. E.;
Essink-Bot, M. L.

Publication type:

journal article

High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer.

Published in:

2010

By:

Berthier, A.;
Seguin, S.;
Sasco, A. J.;
Bobin, J. Y.;
De Laroche, G.;
Datchary, J.;
Saez, S.;
Rodriguez-Lafrasse, C.;
Tolle, F.;
Fraichard, A.;
Boyer-Guittaut, M.;
Jouvenot, M.;
Delage-Mourroux, R.;
Descotes, F.

Publication type:

journal article

'Desperate house genes': the dramatic example of hypoxia.

Published in:

2010

By:

Caradec, J.;
Sirab, N.;
Keumeugni, C.;
Moutereau, S.;
Chimingqi, M.;
Matar, C.;
Revaud, D.;
Bah, M.;
Manivet, P.;
Conti, M.;
Loric, S.

Publication type:

journal article

Identification of DBC1 as a transcriptional repressor for BRCA1.

Published in:

2010

By:

Hiraike, H.;
Wada-Hiraike, O.;
Nakagawa, S.;
Koyama, S.;
Miyamoto, Y.;
Sone, K.;
Tanikawa, M.;
Tsuruga, T.;
Nagasaka, K.;
Matsumoto, Y.;
Oda, K.;
Shoji, K.;
Fukuhara, H.;
Saji, S.;
Nakagawa, K.;
Kato, S.;
Yano, T.;
Taketani, Y.

Publication type:

journal article

Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres.

Published in:

2010

By:

Pressoir, M.;
Desné, S.;
Berchery, D.;
Rossignol, G.;
Poiree, B.;
Meslier, M.;
Traversier, S.;
Vittot, M.;
Simon, M.;
Gekiere, J. P.;
Meuric, J.;
Serot, F.;
Falewee, M. N.;
Rodrigues, I.;
Senesse, P.;
Vasson, M. P.;
Chelle, F.;
Maget, B.;
Antoun, S.;
Bachmann, P.

Publication type:

journal article

Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction.

Published in:

2010

By:

Neville-Webbe, H. L.;
Coleman, R. E.;
Holen, I.

Publication type:

journal article

Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.

Published in:

2010

By:

Hsu, C.-H.;
Yang, T.-S.;
Hsu, C.;
Toh, H. C.;
Epstein, R. J.;
Hsiao, L.-T.;
Chen, P.-J.;
Lin, Z.-Z.;
Chao, T.-Y.;
Cheng, A.-L.

Publication type:

journal article

KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?

Published in:

2010

By:

Lopez-Crapez, E.;
Mineur, L.;
Emptas, H.;
Lamy, P.-J.

Publication type:

Letter

Reply: KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?

Published in:

2010

By:

Cremolini, C.;
Ruzzo, A.;
Graziano, F.;
Falcone, A.;
Loupakis, F.

Publication type:

Letter

Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experience.

Published in:

2010

By:

Sutherland, S.;
Ashley, S.;
Miles, D.;
Chan, S.;
Wardley, A.;
Davidson, N.;
Bhatti, R.;
Shehata, M.;
Nouras, H.;
Camburn, T.;
Johnston, S. R. D.

Publication type:

journal article

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.

Published in:

2010

By:

Bray, J.;
Sludden, J.;
Griffin, M. J.;
Cole, M.;
Verrill, M.;
Jamieson, D.;
Boddy, A. V.

Publication type:

journal article

Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.

Published in:

2010

By:

Panupinthu, N.;
Lee, H. Y.;
Mills, G. B.

Publication type:

journal article

High-resolution genomic profiling of human papillomavirus-associated vulval neoplasia.

Published in:

2010

By:

Purdie, K. J.;
Harwood, C. A.;
Gibbon, K.;
Chaplin, T.;
Young, B. D.;
Cazier, J. B.;
Singh, N.;
Leigh, I. M.;
Proby, C. M.

Publication type:

journal article

The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.

Published in:

2010

By:

Huang, J.;
Chen, K.;
Chen, J.;
Gong, W.;
Dunlop, N. M.;
Howard, O. M. Z.;
Gao, Y.;
Bian, X-w;
Wang, J. M.

Publication type:

journal article

Are GPs under-investigating older patients presenting with symptoms of ovarian cancer? Observational study using General Practice Research Database.

Published in:

2010

By:

Tate, A. R.;
Nicholson, A.;
Cassell, J. A.

Publication type:

journal article

A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo.

Published in:

2010

By:

Hovland, S.;
Arbyn, M.;
Lie, A. K.;
Ryd, W.;
Borge, B.;
Berle, E. J.;
Skomedal, H.;
Kadima, T. M.;
Kyembwa, L.;
Billay, E. M.;
Mukwege, D.;
Chirimwami, R. B.;
Mvula, T. M.;
Snijders, P. J.;
Meijer, C. J. L. M.;
Karlsen, F.

Publication type:

journal article

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.

Published in:

2010

By:

Zarate, R.;
Rodríguez, J.;
Bandres, E.;
Patiño-Garcia, A.;
Ponz-Sarvise, M.;
Viudez, A.;
Ramirez, N.;
Bitarte, N.;
Chopitea, A.;
Gacía-Foncillas, J.;
Rodríguez, J;
Patiño-Garcia, A;
Gacía-Foncillas, J

Publication type:

journal article

Letter to the Editor: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival.

Published in:

2010

By:

Nuijten, M.;
Mickisch, G.

Publication type:

Correction Notice

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.

Published in:

2010

By:

Ng, K.;
Wolpin, B. M.;
Meyerhardt, J. A.;
Wu, K.;
Chan, A. T.;
Hollis, B. W.;
Giovannucci, E. L.;
Stampfer, M. J.;
Willett, W. C.;
Fuchs, C. S.

Publication type:

Correction Notice

MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea.

Published in:

2010

By:

McDaid, J. R.;
Loughery, J.;
Dunne, P.;
Boyer, J. C.;
Downes, C. S.;
Farber, R. A.;
Walsh, C. P.

Publication type:

Correction Notice